TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)

Direct award
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Intelligence
Published evidence · v1
Prepared 7 Sept 2026, 16:20 BST
A pre-calculated analytical view of official UK procurement facts, competition benchmarks and decision timelines.
Bid readiness
Review notice
Submission deadline not published
Check official notice for submission route
Scope structure
1lots
1 lot · 1 published item
CPV family not published
Decision Velocity
~52 days
Typical sector award window after deadline
Sector median: 52 days
Contract lifecycle
Not published
No future linked contract end in retained records
No published extension signal
Pricing & Budget Savings
£670,000
Contract/award value: £670,000
1 award supplier linked
Bidding Competition
Not published
SME bid count not published
No bid spread metrics published
Sector Market Benchmark (CPV 33)
Based on 74 published procedures
Median Winning Discount
41.96%
Award reduction below published budget
Typical Bids Received
3 bidders
Median competitive participation in sector
Typical Evaluation Window
52 days
Median time between deadline and award
Top Contenders in this Sector (CPV 33)
Active commercial suppliers winning public contracts in this field
SupplierAwards won in sectorTotal awarded valueAvg. winning discount
Medtronic Limited
42 contracts£11,274,871,284-48.5% below budget
Baxter Healthcare Ltd
40 contracts£2,128,139,644At ceiling / not disclosed
B. Braun Medical Limited
35 contracts£2,136,030,424-59.1% below budget
Teva UK Limited
30 contracts£834,774,799-59.1% below budget
Glenmark Pharmaceuticals Europe Ltd
26 contracts£1,018,605,826-59.1% below budget
NORTHERN HOSPITAL SUPPLIES LTD
23 contracts£6,514,396,855At ceiling / not disclosed
Fannin Limited
23 contracts£3,563,512,187At ceiling / not disclosed
B. Braun Medical Limited
22 contracts£11,516,824,438At ceiling / not disclosed
Martindale Pharma
22 contracts£770,894,756At ceiling / not disclosed
Sandoz Ltd
22 contracts£19,160,715At ceiling / not disclosed
Evidence coverage
4/12 core inputs published
Standard procedure facts
Comparable published opportunities
Historic records ranked from matching published evidence. They are research comparables, not expected competitors or a price forecast.
No sufficiently evidenced comparable record has been calculated yet.
Method: tender-intelligence-v1. Values and dates are retained OCDS facts; missing source data remains unknown.
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Belfast Health & Social Care Trust: "AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityBelfast Health & Social Care TrustScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & Regime2023/54 · Direct awardEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Belfast Health & Social Care Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Belfast Health & Social Care Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
10Bids / Report (median)
8% of reports have one bid
Supplier ConcentrationHigh Concentration
MET HEALTHCARE LIMITEDTop vendor: 84.49% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 81 active published awards; 25 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority (All Sectors):
No direct historical awards retained specifically in CPV 33; showing top suppliers across overall authority spend.
Supplier NameHistoric AwardsAttributable ValueAvg. Price Discount
MET HEALTHCARE LIMITED1 win£935,340—
RESUSCITATION COUNCIL (UK)1 win£171,640—
Procedure terms
Contracting AuthorityBelfast Health & Social Care Trust
Procedure methodDirect award
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisUKPGA · 2023/54
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published7 Sept 2026, 13:21 BST
Last source update7 Sept 2026, 13:21 BST
Recurring procurementNot published
ClassificationNot published
Delivery areaLocation not published
OCIDocds-h6vhtk-06f379
What is being bought
PROCUREMENT OF AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)
What changed
From the official release history
  1. Official notice release published
    7 Sept 2026, 13:21 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    7 Sept 2026, 13:21 BST
  2. Award pending
    Not published · £670,000
Commercial outcome and competition
Awards
SCIENSUS PHARMA SERVICES LIMITED
£670,000 · Not published · pending · lots 1
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Belfast Health & Social Care Trust

Contracting authority GB-PPON-PLQJ-5727-JCLR
View buyer profile

  • Belfast Health & Social Care Trust
    buyer

    GB-PPON: PLQJ-5727-JCLR
    Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital, Belfast, UKN06, BT12 6BA, GB
    FinanceProcurement@belfasttrust.hscni.net

  • SCIENSUS PHARMA SERVICES LIMITED
    supplier

    GB-COH: 02759609 · GB-PPON: PXLC-2487-LQPH
    20 Eastbourne Terrace, London, UKI32, W2 6LG, GB
    bidsandtenders@sciensus.com
Award and contract changes
Documents (2)
Official links; attachments are not copied
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThese essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement.